Treating periodontal disease may reduce prostate inflammation
the ONA take:
According to a new report published in the journal Dentistry, researchers from Case Western Reserve University School of Dental Medicine and the Departments of Urology and Pathology at University Hospitals Case Medical Center in Cleveland, Ohio, have found that treating gum disease reduced symptoms of prostate inflammation.
For the study, researchers enrolled 27 men with confirmed inflammation of the prostate gland and elevated prostate specific antigen (PSA) levels.
All of the men also had moderate to severe gum disease. Of the 27 participants, 21 had no or mild inflammation, 15 had biopsy-confirmed malignancies, and two had inflammation and malignancy. All were then treated for periodontal disease.
Results showed that despite receiving no prostate treatment, 21 of the 27 participants had decreased PSA levels. Researchers found that those with the highest levels of prostate inflammation benefited the most from gum disease treatment.
"This study shows that if we treat the gum disease, it can improve the symptoms of prostatitis and the quality of life for those who have the disease," said Nabil Bissada, chair of Case Western Reserve's Department of Periodontics and the new study's corresponding author.
Treating gum disease reduced symptoms of prostate inflammation.
Sign Up for Free e-newsletters
- Education May Better Equip Nurses to Hold End-of-Life Conversations in Advanced Cancer
- Avoiding the ED: Planned Strategies for Unplanned Urgent Cancer Care
- NP-Led Clinics Improved Phase 1 Oncology Study Operations, Outcomes
- Accurate Understanding of Capacity May Improve Workflow, Efficiency in Infusion Suite
- Art as Palliative Care: Bedside Intervention Improves Pain, Anxiety, Mood in Hospitalized Cancer Patients
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|